4 March 2020
Northamber PLC
("Northamber" or the "Company")
Transaction in Own Shares and interim dividend timetable
Northamber (AIM: NAR) a nnounces that today it purchased 100,000 of its 1p ordinary shares at an average price paid per share of 68p.
The number of shares purchased represented 0.36% of the voting rights attributable to the total ordinary shares in issue prior to such purchase.
The 100,000 ordinary shares which have been purchased today, in addition to the 25,000 ordinary shares already held in treasury will be cancelled. Therefore, the total number of ordinary shares carrying voting rights will be 27,231,586.
Total voting rights
The figure of 27,231,586 ordinary shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Individual transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the individual purchases made by Cantor Fitzgerald on behalf of the Company.
|
Number of shares purchased |
Transaction price (pence per share) |
Execution venue |
|
100,000 |
68.0 |
AIMX |
Interim dividend timetable
The Company also wishes to clarify its interim dividend timetable is as follows:
Ex-dividend date: 16 April 2020
Record date: 17 April 2020
Payment date: 15 May 2020
For more information, please contact:
|
Cantor Fitzgerald Europe (Nominated Adviser & Broker) |
020 7894 7000 |
|
Phil Davies / Michael Boot |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.